Results showed that SHOX2/RASSF1A methylation in either BALF or plasma had no statistically significant correlation with any of the collected clinicopathological variables, including gender, age, tumor pathological type, and tumor differentiation degree (P > .05). This evidence concerns the gene RASSF1 and neoplasm.